PT-141 Cycle Guide

What Is PT-141 and Why Does Dosing Matter?

PT-141 (Bremelanotide) is a Melanocortin receptor agonist. Synthetic α-MSH analog targeting MC1R and MC4R for sexual desire modulation. Getting the dosage right is critical — too little may produce no measurable effect, while excessive amounts increase risk without proportional benefit.

The standard research dosage for PT-141 has been established through preclinical studies and community protocols. This guide covers the evidence-backed dosing range, timing, and cycle structure.

What Is the Recommended PT-141 Dosage?

The most widely used PT-141 dosage is 1.75 mg per dose (FDA-approved), administered on-demand, 45 minutes before anticipated activity; maximum 8 doses per month via subcutaneous self-injection.

Beginners should start at the lower end of this range and titrate upward only if needed. The half-life of PT-141 is peak effects 15-30 minutes post-injection, which directly determines how often you need to dose to maintain stable blood levels.

For PT-141 specifically, the on-demand acute dosing; no continuous cycle required cycle length is standard. Longer isn't always better — Melanocortin receptor agonist compounds require cycling to maintain receptor sensitivity.

When Should You Dose PT-141?

With a half-life of peak effects 15-30 minutes post-injection, timing your PT-141 administration affects peak blood levels. Most protocols call for on-demand, 45 minutes before anticipated activity; maximum 8 doses per month.

For peptides administered before bed (common with GH-related compounds), the goal is to amplify the natural nocturnal growth hormone pulse. For healing peptides, proximity to the injury site via local injection can improve outcomes.

How Do You Reconstitute PT-141?

PT-141 typically comes as a lyophilized (freeze-dried) powder. Reconstitute with bacteriostatic water — never saline or sterile water, as BAC water contains 0.9% benzyl alcohol that prevents bacterial growth and extends shelf life to 4-6 weeks.

Use our peptide dosing calculator to determine the exact amount of BAC water to add based on your vial size and desired dose per injection.

How Long Should a PT-141 Cycle Last?

Standard PT-141 cycles run on-demand acute dosing; no continuous cycle required. This timeframe is based on the compound's mechanism and the time needed to observe measurable effects.

FDA approved in 2019 based on two Phase 3 trials with 1,267+ premenopausal women showing significant improvements in sexual desire and reduced distress. Well-established safety and efficacy profile.

What Side Effects Can Affect Dosing?

Nausea (40% incidence, especially first injection), flushing (20%), injection site reactions (13%), headache (11%). Transient blood pressure increases (2-3 mmHg average). Contraindicated in uncontrolled hypertension.

If side effects emerge, the first step is typically reducing the dose rather than discontinuing entirely. Most PT-141-related side effects are dose-dependent.

How Does PT-141 Dosing Change When Stacking?

Works through a unique mechanism distinct from PDE5 inhibitors; not typically combined with other sexual enhancement agents.

When stacking, some researchers reduce individual peptide doses by 20-30% since synergistic effects mean full doses of each aren't always necessary.

What Is the Bottom Line on PT-141 Dosing?

Start at 1.75 mg per dose (FDA, dose on-demand, 45 minutes before anticipated activity; maximum 8 doses per month, and run cycles of on-demand acute dosing; no continuous cycle required. Monitor your response and adjust within the established range.

Source matters — always use research-grade PT-141 from vendors with third-party COA testing. Underdosed or contaminated products are the most common reason for poor results.

Related Reading

• PT-141 Benefits
• PT-141 Side Effects
• PT-141 Stacking Guide
• PT-141 Cycle Guide
• PT-141 Research
• ARA-290 Complete Guide

Frequently Asked Questions